In this episode of Derms and Conditions, our host, James Q. Del Rosso, DO, interviews Cory Rubin, MD, dermatologist and owner of the Michigan Dermatology Institute, about the business side of running a practice, with specific focus on the buy-and-bill model.
Dr Rubin shares some of the challenges he has faced and explains the value of buy-and-bill for dermatologists, particularly in complex cases where medications may not be easily accessible through traditional pharmacies. They cover suitable medications, such as biologics for psoriasis, cutaneous T-cell lymphoma, and other conditions, as well as the financial benefits, clinical advantages, and patient convenience associated with in-office administration.
The conversation dives into the practical aspects of implementing buy-and-bill. They explore the importance of understanding insurance processes, obtaining prior authorizations, and tracking patient outcomes. The pair emphasize the need to start small, gradually expanding buy-and-bill capabilities while ensuring proper documentation and reimbursement.
Dr Rubin offers rich practical advice and reiterates the importance of mentorship and seeking assistance from experts in billing and reimbursement. He also extends an invitation for further consultation via email and expresses his willingness to support colleagues in navigating the complexities of practice management. This episode is a valuable listen for dermatologists looking to optimize their practice operations and enhance patient care through buy-and-bill.
Improving Your Clinical Approach To Chronic Urticaria
Outside the Box: The Power of Combining Art and Science
Comprehensive Management of Hidradenitis Suppurativa: Expert Insights From Dr Jennifer Hsiao
Part 2: Special Edition on Recent Reports of Benzene Found in Benzoyl Peroxide Products
Part 1: Special Edition on Recent Reports of Benzene Found in Benzoyl Peroxide Products
Highlights of Winter Clinical Miami 2024
Tapping Into Tapinarof: An In-Depth Look at the Novel Treatment for Psoriasis with Dr April Armstrong
Highlights of Winter Clinical Hawaii 2024
A Deep Dive Into IL-17 Inhibition and Bimekizumab for Psoriasis: Straight Talk with Dr Andy Blauvelt
Final Thoughts from 2023: Highlights from Podcasts Past…
Untangling the Questions and Challenges in Patients with Hair Loss: Part 2
Untangling the Questions and Challenges in Patients with Hair Loss: Part 1
Does Bimekizumab Raise the Bar of Success for Moderate-to-Severe Plaque Psoriasis? Perspectives from Dr. Ted Rosen
Beyond the Knife: Practical Nonsurgical Options for Skin Cancer
What is Dr Adam Friedman Up To Now?
Live From Las Vegas! Greatest Hits from Fall Clinical Dermatology 2023
Once Is Not Enough: Round 2 on Therapeutic Insights
A Closer Look at How to Address Skin Care With Your Patients
Improving Our Understanding of How Drugs Work: Clarifying Questions with Monoclonal Antibodies and JAK Inhibitors.
Create your
podcast in
minutes
It is Free
The Relaxback UK Show
Good Nurse Bad Nurse
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive